163
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Case Series and a Literature Review: Two Ovarian Clear Cell Carcinoma Cases with Recurrent Endometriosis

ORCID Icon &
Pages 1611-1619 | Received 25 May 2023, Accepted 26 Sep 2023, Published online: 24 Oct 2023

References

  • Mikhaleva LM, Davydov AI, Patsap OI, et al. Malignant transformation and associated biomarkers of ovarian endometriosis: a narrative review. Adv Ther. 2020;37(6):2580–2603. doi:10.1007/s12325-020-01363-5
  • Li B, Wang Y, Wang Y, et al. Deep infiltrating endometriosis malignant invasion of cervical wall and rectal wall with lynch syndrome: a rare case report and review of literature. Front Oncol. 2022;12:832228. doi:10.3389/fonc.2022.832228
  • Matalliotakis M, Matalliotaki C, Trivli A, et al. Keeping an eye on perimenopausal and postmenopausal endometriosis. Diseases. 2019;7(29):1–7. doi:10.3390/diseases7010029
  • Marie-Scemama L, Even M, Joliniere JBDL, et al. Endometriosis and the menopause: why the question merits our full attention. Horm Mol Biol Clin Investig. 2019;37(2):20180071. doi:10.1515/hmbci-2018-0071
  • Murakami K, Kotani Y, Shiro R, et al. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. Int J Clin Oncol. 2020;25:51–58. doi:10.1007/s10147-019-01536-5
  • Olivera K, Bradyb W, Birrer M, et al. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: an NRG oncology/gynecologic oncology group experience. Gynecol Oncol. 2017;147(2):243–249. doi:10.1016/j.ygyno.2017.08.004
  • Sun Y, Liu G. Endometriosis-associated ovarian clear cell carcinoma: a special entity? J Cancer. 2021;12(22):6773–6786. PMCID: PMCPMC8518018. doi:10.7150/jca.61107
  • Chandler RL, Damrauer JS, Raab JR, et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 2015;6:6118. doi:10.1038/ncomms7118
  • Teasley HE, Beesley A, Kim TH, et al. Differential expression of KRAS and SIRT1 in ovarian cancers with and without endometriosis. Reprod Sci. 2020;27(1):145–151. PMID: 32046380. doi:10.1007/s43032-019-00017-4
  • Streuli IGH, Wenger JM, Petignat P, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric. 2017;20(2):138–143. doi:10.1080/13697137.2017.1284781
  • Wang CT, Wang DB, Liu KR, et al. Inducing malignant transformation of endometriosis in rats by long-term sustaining hyperestrogenemia and type II diabetes. Cancer Sci. 2015;106(1):43–50. PMID: 25421527; PMCID: PMCPMC4317770. doi:10.1111/cas.12573
  • Horne AW, Saunders PTK. SnapShot: endometriosis. Cell. 2019;179(7):1677- e1. PMID: 31951524. doi:10.1016/j.cell.2019.11.033
  • Makrydimas G, Sotiriadis A, Paraskevaidis E, et al. Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment. Eur J Gynaecol Oncol. 2003;24(5):438–441.
  • Saylam K, Devreker F, Simon P, et al. Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations. Acta Obstet Gynecol Scand. 2006;85(12):1506–1507. doi:10.1080/00016340600603577
  • Murta EF, Nomelini RS, Ferreira FA, et al. Ovarian clear cell carcinoma associated with endometriosis: a case report with immunohistochemical study. Eur J Gynaecol Oncol. 2007;28(5):403–405.
  • Matsuo K, Alonsozana EL, Eno ML, et al. Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery. Arch Gynecol Obstet. 2009;280(4):637–641. PMID: 19219617. doi:10.1007/s00404-009-0962-y
  • Fujiu K, Miyamoto H, Hashimoto S, et al. A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis. Int J Clin Oncol. 2010;15(5):489–492. doi:10.1007/s10147-010-0052-y
  • Pergialiotis V, Lagkadas A, Polychronis O, et al.; Endometriosis-associated ovarian cancer. Presentation of a case report and review of the literature. Eur J Gynaecol Oncol. 2011;32(6):682–685. PMID: 22335037.
  • Shang HS, Chao TK, Wu GZ, et al. A rare case of the coexistence of ovarian clear cell carcinoma, mucinous cystadenoma, and endometriosis in the same ovary. Eur J Gynaecol Oncol. 2011;32(6):677–679.
  • Takahashi Y, Mogami H, Hamada S, et al. Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: a case report. J Obstet Gynaecol Res. 2011;37(12):1842–1846. doi:10.1111/j.1447-0756.2011.01622.x
  • Win TT, Nik Mahmood NMZ, Ma SO, et al. Bilateral ovarian clear cell carcinoma arising in 17 year longstanding history of bilateral ovarian endometriosis. Iran J Pathol. 2016;11(5):478–482.
  • Zhou ZN, Tierney C, Rodgers WH, et al. Ruptured clear cell carcinoma of the ovary presenting as acute abdomen. Gynecol Oncol Rep. 2016;16:1–4. doi:10.1016/j.gore.2016.01.003
  • Komiyama S, Nagashima M, Taniguchi T, et al. Ovarian clear cell carcinoma detected during long-term management of endometriotic cysts in young patients: possible heterogeneity of this tumor. Gynecol Obstet Invest. 2019;84(3):305–312. doi:10.1159/000494256
  • Uehara T, Yoshida H, Tate K, et al. Metachronous occurrence of two different histological subtypes of endometriosis-related neoplasms. Gynecol Oncol Rep. 2019;27:42–45. doi:10.1016/j.gore.2018.12.007
  • Matsubara S, Kawahara N, Horie A, et al. Magnetic resonance relaxometry improves the accuracy of conventional MRI in the diagnosis of endometriosis-associated ovarian cancer: a case report. Mol Clin Oncol. 2019;11(3):296–300. doi:10.3892/mco.2019.1889
  • Inamdar A, Fulginiti A, Yiu SF, et al. Metastatic ovarian clear cell carcinoma in the context of in vitro fertilization pregnancy. Case Rep Obstet Gynecol. 2020;2020:2695058. doi:10.1155/2020/2695058
  • Negrão E, Flor-de-lima B, Duarte AL, et al. Ovarian clear cell carcinoma arising in a large endometrioma - A case report with pathological correlation and literature review. Radiol Case Rep. 2022;17(8):2806–2811. doi:10.1016/j.radcr.2022.05.015
  • Mendoza Stanteen S, Pak T, Chen H, et al. Clear cell carcinoma arising from ovarian and thoracic endometriosis: a case report and review of literature. Case Rep Obstet Gynecol. 2022;2022:7624305. doi:10.1155/2022/7624305
  • Farah AM, Gu S, Jia Y. Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: a case report. Medicine. 2022;101(37):e30666. PMCID: PMCPMC9478318. doi:10.1097/MD.0000000000030666
  • Hermens M, van Altena AM, Nieboer TE, et al. Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Am J Obstet Gynecol. 2020;223(1):107 e1- e11. doi:10.1016/j.ajog.2020.01.041
  • Min KW, Park MH, Hong SR, et al. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3. Int J Gynecol Pathol. 2013;32(1):3–14. PMID: 23202783. doi:10.1097/PGP.0b013e31825554e9
  • Ho CM, Huang YJ, Chen TC, et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol. 2004;94(1):197–203. doi:10.1016/j.ygyno.2004.04.004
  • Bartiromo L, Schimberni M, Villanacci R, et al. A systematic review of atypical endometriosis-associated biomarkers. Int J Mol Sci. 2022;23(8):4425. PMID: 35457244; PMCID: PMCPMC9029517. doi:10.3390/ijms23084425
  • Penciu RC, Postolache I, Steriu L, et al. Is there a relationship in-between ovarian endometriosis and ovarian cancer? Immunohistochemical profile of four cases with coexisting ovarian endometriosis and cancer. Rom J Morphol Embryol. 2020;61(1):157–165. PMID: 32747907; PMCID: PMCPMC7728120. doi:10.47162/RJME.61.1.18
  • Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99(4):653–658. PMID: 18377417. doi:10.1111/j.1349-7006.2008.00747.x
  • Takahashi N, Hatakeyama K, Nagashima T, et al. Characterization of rare histological subtypes of ovarian cancer based on molecular profiling. Cancer Med. 2023;12(1):387–395. PMID: 35676859; PMCID: PMCPMC9844652. doi:10.1002/cam4.4927
  • Yamanaka S, Kawahara N, Kawaguchi R, et al. The comparison of three predictive indexes to discriminate malignant ovarian tumors from benign ovarian endometrioma: the characteristics and efficacy. Diagnostics. 2022;12:1212. doi:10.3390/DIAGNOSTICS12051212
  • Buehner TM, Liotta M, Potkul RK, et al. Initial experience with the radiotracer 18F-fluciclovine PET/CT in ovarian cancer. Mol Imaging Biol. 2023. PMID: 36754935. doi:10.1007/s11307-023-01807-8
  • American Cancer Society. Key statistics for ovarian cancer. American Cancer Society; 2023. Available from: https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html. Accessed October 16, 2023.